Literature DB >> 34716903

Blastoid Mantle Cell Lymphoma of the Palate: Report of a Rare Aggressive Entity and Review of the Literature.

Maria Georgaki1, Vasileios Ionas Theofilou2,3, Efstathios Pettas2, Evangelia Piperi2, Eleana Stoufi2, Panayiotis Panayiotidis4, Nikolaos G Nikitakis2.   

Abstract

Mantle cell lymphoma (MCL) is a well-defined, non-Hodgkin lymphoma of B-cell origin displaying diverse morphological phenotypes and variable disease course. The World Health Organization recognizes two aggressive histopathologic variants of this type of lymphoma: pleomorphic and blastoid MCL. To date, only few cases of MCL affecting the oral cavity have been reported. Additionally, the involvement of the oral and maxillofacial area by aggressive MCL subsets is considered extremely rare with only two patients reported in the English language literature to the best of our knowledge. Herein, we describe a 69 year-old male with a prior history of MCL of the right lateral pharyngeal wall developing a recurrent lesion extending to the palatal mucosa as diffuse ulceration and exhibiting histomorphological features of blastoid MCL. We also review the pertinent literature with emphasis on the diagnostic challenges and distinction between the different MCL variants.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Blastoid variant; Head and neck neoplasms; Mantle cell lymphoma; Non-Hodgkin lymphoma; Oral lymphoma; Pleomorphic variant

Mesh:

Year:  2021        PMID: 34716903      PMCID: PMC9187827          DOI: 10.1007/s12105-021-01391-9

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  33 in total

1.  Involvement of the appendix and palate by pleomorphic variant mantle cell lymphoma.

Authors:  Kong-Bing Tan; Leonard H C Tan; Ross Soo; Thomas C Putti; Siew-Meng Chong
Journal:  Leuk Lymphoma       Date:  2006-08

2.  A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project.

Authors: 
Journal:  Blood       Date:  1997-06-01       Impact factor: 22.113

3.  CD5-negative Mantle Cell Lymphoma: Clinicopathologic Correlations and Outcome in 58 Patients.

Authors:  Yuan Miao; Pei Lin; Annapurna Saksena; Jie Xu; Michael Wang; Jorge Romaguera; C Cameron Yin; L Jeffrey Medeiros; Shaoying Li
Journal:  Am J Surg Pathol       Date:  2019-08       Impact factor: 6.394

4.  Pleomorphic mantle cell lymphoma morphologically mimicking diffuse large B cell lymphoma: common cyclin D1 negativity and a simple immunohistochemical algorithm to avoid the diagnostic pitfall.

Authors:  Wen-Yu Chuang; Hung Chang; Gwo-Jyh Chang; Tzu-Hao Wang; Yu-Sun Chang; Tong-Hong Wang; Chi-Ju Yeh; Shir-Hwa Ueng; Hui-Ping Chien; Chiu-Yueh Chang; Yung-Liang Wan; Chuen Hsueh
Journal:  Histopathology       Date:  2017-03-10       Impact factor: 5.087

5.  CD5- mantle cell lymphoma.

Authors:  Zach Liu; Henry Y Dong; Wojciech Gorczyca; Patricia Tsang; Patti Cohen; Christine F Stephenson; Carol S Berger; C Daniel Wu; James Weisberger
Journal:  Am J Clin Pathol       Date:  2002-08       Impact factor: 2.493

Review 6.  Mantle cell lymphoma of the oral cavity: case series and comprehensive review of the literature.

Authors:  Kelly Guggisberg; Richard C K Jordan
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2009-10-31

7.  Increase in survival for patients with mantle cell lymphoma in the era of novel agents in 1995-2013: Findings from Texas and national SEER areas.

Authors:  Shuangshuang Fu; Michael Wang; Ruosha Li; David R Lairson; Bo Zhao; Xianglin L Du
Journal:  Cancer Epidemiol       Date:  2018-12-06       Impact factor: 2.890

8.  Mantle cell lymphoma: involvement of nodal and extranodal sites in the head and neck, with multifocal oral lesions.

Authors:  Marcelo Marcucci; Gilberto Marcucci; Mirna Scalon Cordeiro; Jorge Esquiche León; Juliane Piragine Araujo; Jefferson Xavier de Oliveira; Karina Cecília Panelli Santos
Journal:  Autops Case Rep       Date:  2017-09-30

Review 9.  Mantle cell lymphoma and its management: where are we now?

Authors:  Abdullah Ladha; Jianzhi Zhao; Elliot M Epner; Jeffrey J Pu
Journal:  Exp Hematol Oncol       Date:  2019-01-30

10.  Trends and variations in mantle cell lymphoma incidence from 1995 to 2013: A comparative study between Texas and National SEER areas.

Authors:  Shuangshuang Fu; Michael Wang; David R Lairson; Ruosha Li; Bo Zhao; Xianglin L Du
Journal:  Oncotarget       Date:  2017-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.